Ipek Erdogan-Trinkaus insider trades

Open-market stock purchases and sales by Ipek Erdogan-Trinkaus, Chief Commercial Officer at Eton Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 12, 2025.

Recent trades

DateStockTradeValue
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Jan 12, 2026ETON Eton Pharmaceuticals, IncBought (not open market)—
Dec 12, 2025ETON Eton Pharmaceuticals, IncSold (not open market)$1.4K

Companies traded

  • ETON Eton Pharmaceuticals, Inc: other filings, last Jan 12, 2026

Get free alerts when Ipek Erdogan-Trinkaus files a new trade →